Recent advances in injectable hydrogel-mediated myocardial infarction therapy

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Myocardial infarction (MI) triggers adverse remodeling mechanisms, thus leading to heart failure.

Lilly gets June adcomm for Alzheimer’s drug donanemab, following earlier delay

Eli Lilly will face questions from a panel of Alzheimer’s experts on June 10, setting up an approval decision for donanemab after a surprise delay

May 8, 2024

Abbott’s dissolvable stent, which failed in heart disease patients, may help vascular patients

An Abbott device that failed in heart disease patients is getting a new life in patients with severe vascular disease. The device is a below-knee

May 15, 2024

Madrigal to grapple with lack of awareness about NASH ahead of potential FDA approval

Madrigal Pharmaceuticals may be first in line to bring a NASH drug to market, but the company is also tasked with teaching Americans and their

March 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.